Send to

Choose Destination
Int J Hyperthermia. 2017 Jan 31:1-12. doi: 10.1080/02656736.2016.1277791. [Epub ahead of print]

Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements.

Author information

a Signals and Systems , Chalmers University of Technology , Göteborg , Sweden.
b Radiotherapy , AMC , Amsterdam , The Netherlands.
c Radiotherapy Clinics, Universitatsklinikum Erlangen , Erlangen , Germany.
d Kantonsspital Aarau , Aarau , Switzerland.
e Radiation Oncology , University Hospital Tuebingen , Tuebingen , Germany.
f Radiation Oncology , University Medical Centre Mannheim , Mannheim , Germany.
g Klinik für Radioonkologie und Strahlentherapie , Campus Virchow Klinikum, Charite Universitatsmedizin Berlin , Berlin , Germany.
h Praxis/Zentrum für Strahlentherapie und Radioonkologie , Berlin , Germany.
i Radiation Oncology , Erasmus MC Daniel den Hoed Cancer Center , Rotterdam , The Netherlands.
j Department of Internal Medicine III , Ludwig Maximilians University of Munich , Munich , Germany.
k Department of Biophysics , GSI - Helmholtz Centre for Heavy Ion Research , Darmstadt , Germany.
l Department of Radiation Oncology , Thomas Jefferson University , Philadelphia , PA , USA.
m Department of Radiation Oncology , UCSF , San Francisco , CA , USA.


Quality assurance guidelines are essential to provide uniform execution of clinical trials and treatment in the application of hyperthermia. This document provides definitions for a good hyperthermia treatment and identifies the clinical conditions where a certain hyperthermia system can or cannot adequately heat the tumour volume. It also provides brief description of the characteristics and performance of the current electromagnetic (radiative and capacitive), ultrasound and infra-red heating techniques. This information helps to select the appropriate heating technique for the specific tumour location and size, and appropriate settings of the water bolus and thermometry. Finally, requirements of staff training and documentation are provided. The guidelines in this document focus on the clinical application and are complemented with a second, more technical quality assurance document providing instructions and procedure to determine essential parameters that describe heating properties of the applicator for superficial hyperthermia. Both sets of guidelines were developed by the ESHO Technical Committee with participation of senior STM members and members of the Atzelsberg Circle.


Quality assurance; clinical; hyperthermia; superficial

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center